- Home
- VNDA vs HBB Comparison
VNDA vs HBB Comparison
Compare VNDA & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- HBB
- Stock Information
- Founded
- VNDA 2002
- HBB 1904
- Country
- VNDA United States
- HBB United States
- Employees
- VNDA N/A
- HBB N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- HBB Home Furnishings
- Sector
- VNDA Health Care
- HBB Consumer Discretionary
- Exchange
- VNDA Nasdaq
- HBB Nasdaq
- Market Cap
- VNDA 249.4M
- HBB 242.8M
- IPO Year
- VNDA 2006
- HBB 2017
- Fundamental
- Price
- VNDA $4.75
- HBB $14.96
- Analyst Decision
- VNDA Strong Buy
- HBB
- Analyst Count
- VNDA 2
- HBB 0
- Target Price
- VNDA $16.50
- HBB N/A
- AVG Volume (30 Days)
- VNDA 551.9K
- HBB 39.8K
- Earning Date
- VNDA 07-31-2025
- HBB 07-30-2025
- Dividend Yield
- VNDA N/A
- HBB 3.31%
- EPS Growth
- VNDA N/A
- HBB N/A
- EPS
- VNDA N/A
- HBB 2.35
- Revenue
- VNDA $203,467,000.00
- HBB $631,318,000.00
- Revenue This Year
- VNDA $16.86
- HBB N/A
- Revenue Next Year
- VNDA $39.78
- HBB N/A
- P/E Ratio
- VNDA N/A
- HBB $6.44
- Revenue Growth
- VNDA 11.78
- HBB N/A
- 52 Week Low
- VNDA $3.81
- HBB $12.72
- 52 Week High
- VNDA $5.55
- HBB $31.78
- Technical
- Relative Strength Index (RSI)
- VNDA 60.39
- HBB 49.02
- Support Level
- VNDA $4.47
- HBB $13.41
- Resistance Level
- VNDA $4.88
- HBB $14.01
- Average True Range (ATR)
- VNDA 0.16
- HBB 0.89
- MACD
- VNDA 0.05
- HBB 0.18
- Stochastic Oscillator
- VNDA 82.43
- HBB 72.27
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.